title: Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation.
authors.affiliation: Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York. Electronic address: GiraltS@mskcc.org.
authors.forename: S A
authors.initials: SA
authors.lastname: Giralt
authors.affiliation: Fox Chase Temple BMT Program, Philadelphia.
authors.forename: K F
authors.initials: KF
authors.lastname: Mangan
authors.affiliation: Oregon Health and Science University, Portland.
authors.forename: R T
authors.initials: RT
authors.lastname: Maziarz
authors.affiliation: Oregon Health and Science University, Portland.
authors.forename: J S
authors.initials: JS
authors.lastname: Bubalo
authors.affiliation: Fairfax-Northern Virginia Hematology-Oncology P.C., Fairfax.
authors.forename: R
authors.initials: R
authors.lastname: Beveridge
authors.affiliation: Wake Forest University School of Medicine, Winston-Salem.
authors.forename: D D
authors.initials: DD
authors.lastname: Hurd
authors.affiliation: Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York.
authors.forename: F L
authors.initials: FL
authors.lastname: Mendoza
authors.affiliation: Medical & Scientific Affairs, Eisai Inc., Woodcliff Lake.
authors.forename: E B
authors.initials: EB
authors.lastname: Rubenstein
authors.affiliation: Medical & Scientific Affairs, Eisai Inc., Woodcliff Lake.
authors.forename: T J
authors.initials: TJ
authors.lastname: DeGroot
authors.affiliation: Hematopoietic Stem Cell Transplantation Program, Stony Brook University, Stony Brook, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Schuster